Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study
Authors
Keywords
-
Journal
ACTA DIABETOLOGICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-07
DOI
10.1007/s00592-020-01487-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics
- (2017) Richard L. Dunbar et al. JOURNAL OF LIPID RESEARCH
- Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH
- (2016) Ronald B. Goldberg et al. AMERICAN JOURNAL OF MEDICINE
- Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens
- (2016) Richard L. Dunbar et al. Current Atherosclerosis Reports
- Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part II: Novel Niacin Mimetics
- (2016) Harsh Goel et al. Current Atherosclerosis Reports
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- Postprandial hyperlipidemia as a potential residual risk factor
- (2016) Kazufumi Nakamura et al. Journal of Cardiology
- Saroglitazar for the treatment of dyslipidemia in diabetic patients
- (2015) Shashank R Joshi EXPERT OPINION ON PHARMACOTHERAPY
- Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
- (2013) Eliano Pio Navarese et al. AMERICAN JOURNAL OF CARDIOLOGY
- Discordance between non-HDL-cholesterol and LDL-particle measurements: Results from the Multi-Ethnic Study of Atherosclerosis
- (2013) Emil M. deGoma et al. ATHEROSCLEROSIS
- A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)
- (2013) Kevin C. Maki et al. CLINICAL THERAPEUTICS
- A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI)
- (2013) Rajendrakumar H. Jani et al. Diabetes Technology & Therapeutics
- Pharmacokinetic Interactions of the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide, with Drugs Commonly Used in the Management of Hypercholesterolemia
- (2013) Sony Tuteja et al. PHARMACOTHERAPY
- Extended-release Niacin Acutely Suppresses Postprandial Triglyceridemia
- (2012) M. Haris U. Usman et al. AMERICAN JOURNAL OF MEDICINE
- Standards of Medical Care in Diabetes--2013
- (2012) DIABETES CARE
- Insulin Resistance, Hyperglycemia, and Atherosclerosis
- (2011) Karin E. Bornfeldt et al. Cell Metabolism
- Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
- (2008) Jacob J. Freiberg JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search